# Parambil

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/parambil

- Industry: Software
- Headquarters: New York, US
- Website: www.parambil.com/
- Total disclosed funding: $6M
- Latest round: Seed (Jan 12, 2026)
- Investors on record: 2

## About

Based in the US, Parambil Corp specializes in an AI-powered platform that enhances the efficiency and accuracy of medical record analysis, catering to the legal sector. Parambil Corp, founded in 2023 and headquartered in New York, US, offers an advanced platform for analyzing medical records within legal proceedings. The company secured USD 6.00 mn in Seed funding on January 12, 2026, led by Bling Capital with participation from NVP Capital. This round marked the total amount raised by the company to USD 6.00 mn, indicating strong investor interest. Parambil's core offerings center around an AI-powered platform designed for the meticulous review and analysis of complex medical records within the litigation process. These services aim to enhance the accuracy and efficiency of medical record curation, providing critical insights that support both plaintiff and defense teams in legal cases. Parambil specializes in features such as comprehensive case intake analysis, automated case work-ups, and the generation of polished legal documents, all of which ensure that every detail of the medical records is thoroughly validated and presented in a courtroom-ready format. Their AI-driven medical chronologies allow users to identify critical timelines, correlations, and anomalies across extensive data sets, making the platform invaluable for legal professionals handling mass tort cases. Parambil caters to a diverse client base that includes law firms, legal nurse consultants, and medical experts primarily in the United States and select international markets, where the demand for enhanced legal technology is growing. Parambil operates on a business-to-business model, providing subscription-based access to its suite of AI-driven services. Clients engage with the platform through various transaction structures, where law firms pay for access to specific functionalities such as medical record analysis, case work-ups, and the generation of medical chronologies. Each of these services is tailored to support the litigation process, enabling legal teams to manage complex cases with greater efficiency. The platform's pricing structure reflects the specialized nature of its offerings, ensuring that clients receive high-quality data and insights essential for building strong legal arguments. Parambil's emphasis on delivering accurate medical insights and comprehensive case support positions it as a strategic partner in the resolution of litigation challenges, enhancing its clients' operational effectiveness and case outcomes. In line with its growth strategy, Parambil Corp plans to expand its product offerings by introducing new AI-driven features designed to further streamline legal processes. The company is targeting additional markets in Europe and Asia by 2027, aiming to meet the rising demand for legal technology solutions globally. The recent Seed funding of USD 6.00 mn will support the development of these upcoming features and assist in market entry efforts, allowing Parambil to enhance its service offerings and client reach.

## Funding rounds

- Seed, Jan 12, 2026, $6M — NVP Capital, Bling Capital

## Investors

- NVP Capital — Seed
- Bling Capital (https://capitalatlas.ai/funds/bling-capital) — Seed